Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 14:2020:9130462.
doi: 10.1155/2020/9130462. eCollection 2020.

Efficacy of the Combined Administration of Systemic and Intra-Articular Tranexamic Acid in Total Hip Arthroplasty Secondary to Femoral Neck Fracture: A Retrospective Study

Joseph Maalouly  1 , Antonios Tawk  2 , Rami Ayoubi  1 , Georges Katoul Al Rahbani  2 , Aida Metri  2 , Elias Saidy  1 , Gerard El-Hajj  3 , Alexandre Nehme  1
Affiliations

Efficacy of the Combined Administration of Systemic and Intra-Articular Tranexamic Acid in Total Hip Arthroplasty Secondary to Femoral Neck Fracture: A Retrospective Study

Joseph Maalouly et al. Adv Orthop. .

Abstract

Background: Total hip arthroplasty (THA) is associated with substantial blood loss in the postoperative course. Tranexamic acid (TXA) is a potent antifibrinolytic agent, routinely administered by intravenous (IV) and topical (intra-articular, IA) route, which can possibly interrupt the cascade of events due to hemostatic irregularities close to the source of bleeding. However, scientific evidence of combined administration of TXA in THA secondary to a femoral neck fracture is still meagre. The present study aims to compare the patients who were administered combined IV and topical TXA with a control group in terms of blood loss, transfusion rate, and incidence of deep vein thrombosis (DVT) and thromboembolism (TE). Patients and Methods. 195 patients with femoral neck fracture underwent THA and were placed into two groups: (1) IV and IA TXA group which had 58 patients and (2) no TXA control group which had 137 patients. In the TXA group, 1 g IV TXA was administered 30 minutes before incision, and 1 g IA TXA was administered intraoperatively after fascia closure. No drains were placed, and soft spica was applied to the hip.

Results: Combined usage of IV and IA TXA showed better results when compared to the control group in terms of blood transfusion rate (31%) and hemoglobin drop (28%). No cases of DVT or TE were noted among the two study groups.

Conclusion: Combined use of IV and IA TXA provided significantly better results compared to no TXA use with respect to all variables related to postoperative blood loss in THA. Moreover, TXA use is safe in terms of incidence of symptomatic DVT and TE.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest. They did not receive any outside funding or grants in support of their research work.

Figures

Figure 1
Figure 1
Superiority of the TXA regimen.
See this image and copyright information in PMC

References

    1. Bierbaum B. E., Callaghan J. J., Galante J. O., Rubash H. E., Tooms R. E., Welch R. B. An analysis of blood management in patients having a total hip or knee arthroplasty. The Journal of Bone & Joint Surgery. 1999;81(1):2–10. doi: 10.2106/00004623-199901000-00002. - DOI - PubMed
    1. Kannus P., Haapasalo H., Sankelo M., et al. Possibility to increase women’s bone mass by physical activity wanes rapidly after puberty. Bone. 1996;18(1):S113–S63. doi: 10.1016/s8756-3282(96)80025-1. - DOI
    1. Maceroli M., Nikkel L. E., Mahmood B., et al. Total hip arthroplasty for femoral neck fractures. Journal of Orthopaedic Trauma. 2016;30(11):597–604. doi: 10.1097/bot.0000000000000662. - DOI - PMC - PubMed
    1. Ollivier J. E., Van Driessche S., Billuart F., Beldame J., Matsoukis J. Tranexamic acid and total hip arthroplasty: optimizing the administration method. Annals of Translational Medicine. 2016;4(24) doi: 10.21037/atm.2016.11.53. - DOI - PMC - PubMed
    1. Charoencholvanich K., Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clinical Orthopaedics and Related Research. 2011;469(10):2874–2880. doi: 10.1007/s11999-011-1874-2. - DOI - PMC - PubMed

LinkOut - more resources